Retraction Note: RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine

Oncogene. 2023 Mar;42(14):1157. doi: 10.1038/s41388-023-02627-4.

Authors

Mark S Duxbury¹, Hiromichi Ito¹, Michael J Zinner¹, Stanley W Ashley¹, Edward E Whang²

Affiliations

¹ Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, USA.
² Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, USA. ewhang1@partners.org.

PMID: 36797340
DOI: 10.1038/s41388-023-02627-4

No abstract available

Publication types

Retraction of Publication